Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses

J Neurovirol. 2020 Dec;26(6):929-940. doi: 10.1007/s13365-020-00913-5. Epub 2020 Oct 14.

Abstract

The emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing global health crises. Children can be infected, but are less likely to develop severe neurological abnormalities compared with adults. However, whether SARS-CoV-2 can directly cause neurological impairments in pediatric patients is not known. The possible evolutionary and molecular relationship between SARS-CoV-2 and non-segmented RNA viruses were examined with reference to neurological disorders in pediatric patients. SARS-CoV-2 shares similar functional domains with neuroinvasive and neurotropic RNA viruses. The Spike 1 (S1) receptor binding domain and the cleavage sites at S1/S2 boundary are less conserved compared with the S2 among coronaviruses.

Keywords: Conserved domain; Genome; Multiple sequence alignment; Neuroinvasive and neurotrophic non-segmented RNA viruses; Pediatric patients; Phylogenetic tree; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Spike protein.

Publication types

  • Comparative Study

MeSH terms

  • COVID-19*
  • Child
  • Child, Preschool
  • Computational Biology
  • Female
  • Humans
  • Infant
  • Male
  • Nervous System Diseases / virology*
  • Phylogeny
  • RNA Viruses / genetics*
  • RNA Viruses / pathogenicity
  • SARS-CoV-2 / genetics*
  • Spike Glycoprotein, Coronavirus
  • Virulence

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2